Skip to search formSkip to main contentSkip to account menu

ABT 378

Known as: ABT-378, ABT378 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

lopinavir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Identifying and Characterizing HIV Protease Inhibitors.
HIV protease catalyzes the hydrolysis of specific peptide bonds of viral polyproteins, thus processing these polyproteins into… 
1999
1999
Genotypic Correlates of Reduced In Vitro Susceptibility to ABT-378 in HIV Isolates From Patients Failing Protease Inhibitor Therapy
1999
1999
Early access program for ABT-378/r.
In September, Abbott Laboratories announced its expanded access program for ABT-378/r. The drug is a combination of the… 
Review
1999
Review
1999
ABT-378 early access program begins.
The new protease inhibitor ABT-378/r, which is ABT-378 combined with a small amount of Ritonavir, is available to a limited… 
1999
1999
New anti-HIV drugs in development.
Updates are provided for new anti-HIV drugs currently in development. ABT-378, Tipranavir, and DMP-450 are among the new… 
1999
1999
Expanded access program for ABT-378 under way.
Abbott Laboratories has approximately 300 slots available in the expanded access program for ABT-378/ritonavir. ABT-378… 
1998
1998
Looking down the drug pipeline.
Reports at the 5th Conference on Retroviruses and Opportunistic Infections addressed new anti-HIV agents in primary phases of… 
1997
1997
ABT-378: Abbott "second generation" protease inhibitor.
Abbott Laboratories has released the first public data on ABT-378, a new generation protease inhibitor that is designed to be… 
1997
1997
Protease inhibitors: resistance, resistance, resistance.
Current anti-HIV drugs are plagued by problems with development of resistance. Reports at the 4th Annual Conference on… 
1997
1997
ICAAC and Hamburg: Part 2. The dry salvages or, what to do with two protease inhibitors.
The question of what to do when HIV patients are faced with flagging antiretroviral potency is examined, including discussions…